NVision Imaging Technologies
Ulm
About NVision Imaging Technologies
NVision has developed a platform which polarizes natural metabolites, enabling these safe molecules to be used as an agent for imaging tumor metabolism via MRI. The company's technology uses quantum physics advances to disrupt the medical imaging and diagnostics space by allowing standard Magnetic Resonance Spectrometers to assess human metabolism, allowing healthcare professionals to perform advanced cancer diagnosis and real-time monitoring of response to therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $100.2M
- Funding stage: Early Stage Venture
- Last round: Grant (Jan 2025)
- Website: nvision-imaging.com
Industries & Categories
Biopharma, Biotechnology, Health Diagnostics, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nvision-imaging-technologies-27358 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.